{"disease":{"id":"advanced-head-neck-and-chest-cancer","name":"advanced head neck and chest cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04203719","title":"A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":140,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}